Now, fibromyalgia is making a potential appearance on this management list, according to a Medscape article Reporting on a large-scale health records analysis, the article states The use of GLP-1 receptor agonists was linked to lower pain and fatigue in patients with fibromyalgia The way that I use it in my practice these days is that if I have a patient with chronic pain or with fibromyalgia who has comorbidities that already have an FDA approval for GLP-1 use, such as obesity, diabetes, or obstructive sleep apnea, I would encourage them to go to their primary care physician and maybe consider getting started on a GLP-1, said presenter Nouran Eshak, MB ChB, of the Mayo Clinic in Scottsdale, Arizona. However, the article also lists several limitations to the study including Researchers were unable to account for confounders such as duration of illness, symptom severity, GLP-1 dosage, or access to healthcare. Disclaimer: This post is not a recommendation, rather just a report
The biologic effects of IL-5 are mediated through interaction with IL-5R and a non-specific beta chain heterodimer, recognized by IL-3 and GM-CSF (Rossjohn et al., 2000)
Although BPC-157 isnt approved by the U.S
Early stages of the disease do not cause symptoms, but later stages can cause severe liver damage
Patients with chronic mold illness often report gastrointestinal symptoms such as bloating, food sensitivities, nausea, or IBS-like presentations in conjunction with brain fog, dizziness, fatigue, and emotional lability 23
